NYSE - Nasdaq Real Time Price USD
Fresenius Medical Care AG (FMS)
23.99 +0.28 (+1.20%)
As of 2:36:17 PM EDT. Market Open.
Trade FMS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for FMS
- Previous Close
23.70 - Open
23.82 - Bid 23.95 x 20000
- Ask 23.95 x 70000
- Day's Range
23.74 - 24.00 - 52 Week Range
20.02 - 28.87 - Volume
305,744 - Avg. Volume
708,200 - Market Cap (intraday)
12.883B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
12.83 - EPS (TTM)
1.87 - Earnings Date Aug 4, 2026
- Forward Dividend & Yield 0.87 (3.68%)
- Ex-Dividend Date May 22, 2026
- 1y Target Est
25.32
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
FMS
4.45%
DAX P (^GDAXI)
1.02%
1-Year Return
FMS
8.06%
DAX P (^GDAXI)
4.65%
3-Year Return
FMS
8.70%
DAX P (^GDAXI)
56.29%
5-Year Return
FMS
32.00%
DAX P (^GDAXI)
58.70%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/23/2026
Market Cap
12.73B
Enterprise Value
23.48B
Trailing P/E
12.65
Forward P/E
10.03
PEG Ratio (5yr expected)
0.84
Price/Sales (ttm)
0.61
Price/Book (mrq)
0.84
Enterprise Value/Revenue
1.06
Enterprise Value/EBITDA
6.01
Financial Highlights
Profitability and Income Statement
Profit Margin
4.88%
Return on Assets (ttm)
3.63%
Return on Equity (ttm)
7.85%
Revenue (ttm)
19.36B
Net Income Avi to Common (ttm)
944.68M
Diluted EPS (ttm)
1.87
Balance Sheet and Cash Flow
Total Cash (mrq)
1.24B
Total Debt/Equity (mrq)
77.75%
Levered Free Cash Flow (ttm)
1.67B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
29.20
+1.87%
Mkt Cap 3.736B
Industry Medical Care Facilities
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreFresenius Medical Care: Shares Look Attractive, Despite Market Uncertainty Around Margin Trajectory
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
RatingPrice TargetFresenius Medical Care Earnings: Mild Profit Growth and Maintained Outlook Cut Into Shares
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
RatingPrice TargetFresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
RatingPrice TargetFresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
RatingPrice Target